Investors Watch BKCG After Nvidia, Eli Lilly Earnings

Investors are increasing interest in BNY Mellon Concentrated Growth ETF (BKCG) after strong earnings from Nvidia and Eli Lilly. The fund’s net asset value rose 17.05% over the 12 months ending May 31, 2026.

Nvidia reported Q1 2027 revenue of $81 billion, an 85% increase from Q1 2026. Data-center revenue rose about 92% versus the prior year. Eli Lilly reported $19.8 billion in Q1 2026 revenue, roughly 52% higher than a year earlier and above analyst estimates.

BKCG is an actively managed ETF that holds a concentrated set of U.S. large-cap growth stocks. As of June 2, 2026, the fund’s reported core holdings included Nvidia and Eli Lilly. Fund managers focus on sectors they expect to grow over a three- to five-year horizon and use fundamental research to select companies with strong balance sheets, expanding global footprints and competitive positions.

The fund’s NAV gain of 17.05% for the year through May 31, 2026 reflects the performance of its holdings over that period. BKCG follows a buy-and-hold approach with a smaller portfolio of high-conviction names rather than seeking to replicate a broad index.

Market conditions remain mixed. Geopolitical conflicts have arisen, energy prices have been volatile and some inflation measures have prompted concern about rising price pressures. At the same time, several large companies have reported sharply higher profits, producing divergence between company-level momentum and broader economic uncertainty.

Advisors and investors considering BKCG and similar concentrated funds face trade-offs between potential higher returns when top holdings outperform and higher idiosyncratic risk if single positions fall. The fund’s holdings, strategy and recent performance have led market participants to review concentrated large-cap growth exposure.